Recruiting
Phase 1

RNA-NP Vaccine

Sponsor:

University of Florida

Code:

NCT05264974

Conditions

Melanoma

Soft Tissue Sarcoma

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Autologous total tumor mRNA loaded DOTAP liposome vaccine

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-02-03. This information was provided to ClinicalTrials.gov by University of Florida on 2026-01-21.